We first confirmed that LCLs from patients with DS (T21, Table 4) overexpressed 1.5 fold DYRK1A at the mRNA and protein level compared to LCLs from control individuals (control, Table 4). The gene discussed is DYRK1A; the disease is Dravet syndrome.